The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo
Open accessAbstract
Microtubules are cylindrical cytoskeletal structures found in almost all eukaryotic cell types which are involved in a great variety of cellular processes. Reversible acetylation on the epsilon-amino group of alpha-tubulin Lys40 marks stabilized microtubule structures and may contribute to regulating microtubule dynamics. Yet, the enzymes catalysing this acetylation/deacetylation have remained unidentified until recently. Here we report that beta-tubulin interacts with histone deacetylase-6 (HDAC-6) in a yeast two-hybrid assay and in vitro. We find that HDAC-6 is a micro tubule-associated protein capable of deacetylating alpha-tubulin in vivo and in vitro. HDAC-6's microtubule binding and deacetylation functions both depend on the hdac domains. Overexpression of HDAC-6 in mammalian cells leads to tubulin hypoacetylation. In contrast, inhibition of HDAC-6 function by two independent mechanisms--pharmacological (HDAC inhibitors) or genetic (targeted inactivation of HDAC-6 in embryonic stem cells)--leads to hyperacetylation of tubulin and microtubules. Taken together, our data provide evidence that HDAC-6 might act as a dual deacetylase for tubulin and histones, and suggest the possibility that acetylated non-histone proteins might represent novel targets for pharmacological therapy by HDAC inhibitors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the class IIb isozyme, HDAC6, has been associated with deacetylation of several cytosolic substrates including a -tubulin and p53 (Hubbert et al., 2002; Zhang et al., 2003; Ryu et al., 2017).”
From Histone deacetylase 11 is an ε-N-Myristoyllysine hydrolase (2018) · cites this paper as Zhang et al., 2003
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756
A novel genetic system to detect protein–protein interactions
Fields, S., & Song, O.-K. (1989) · Nature · doi:10.1038/340245a0 · Cited by 6,152
Chen, X., Xiu, M., Xing, J., Yu, S., Min, D., & Guo, F. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479439 · Cited by 5,760
HDAC6 is a microtubule-associated deacetylase
Hubbert, C., Guardiola, A., Shao, R., Kawaguchi, Y., Ito, A., Nixon, A., Yoshida, M., Wang, X.-F., & Yao, T.-P. (2002) · Nature · doi:10.1038/417455a · Cited by 2,403
Histone deacetylases and cancer: causes and therapies
Marks, P. A., Rifkind, R. A., Richon, V. M., Breslow, R., Miller, T., & Kelly, W. K. (2001) · Nature reviews. Cancer · doi:10.1038/35106079 · Cited by 1,866
Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
Finnin, M. S., Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, P. A., Breslow, R., & Pavletich, N. P. (1999) · Nature · doi:10.1038/43710 · Cited by 1,714
Cdi1, a human G1 and S phase protein phosphatase that associates with Cdk2
Gyuris, J. (1993) · Cell · doi:10.1016/0092-8674(93)90498-f · Cited by 1,534
Cooperation between Complexes that Regulate Chromatin Structure and Transcription
Narlikar, G. J., Fan, H.-Y., & Kingston, R. E. (2002) · Cell · doi:10.1016/s0092-8674(02)00654-2 · Cited by 1,486
Richon, V. M., Sandhoff, T. W., Rifkind, R. A., & Marks, P. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.180316197 · Cited by 1,090
Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation
McKinsey, T. A., Zhang, C., Lu, J., & Olson, E. N. (2000) · Nature · doi:10.1038/35040593 · Cited by 1,051
Cited by
Sorted by citations
Items 401–500 of 765
Garrett, L. A., Growdon, W. B., Rueda, B. R., & Foster, R. (2016) · Journal of Ovarian Research · doi:10.1186/s13048-016-0267-2 · Cited by 29
“Acetylated tubulin and acetylated histone H3 are known HDAC targets [47, 48].”
Wang, W., & Brautigan, D. L. (2008) · BMC Cell Biology · doi:10.1186/1471-2121-9-62 · Cited by 27
“Among the multiple histone deacetylases, HDAC-6 has been shown to interact with and catalyze alpha tubulin K40 deacetylation [26,27].”
BackgroundThe Theoretical Basis of Transcriptional Therapy of Cancer: Can It Be Put Into Practice?
Melnick, A. M., Adelson, K. B., & Licht, J. D. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.14.498 · Cited by 29
Wang, Z., Hu, P., Tang, F., & Xie, C. (2016) · Medical Oncology · doi:10.1007/s12032-016-0765-5 · Cited by 28
Jung, H., Jung, J. S., Whang, Y. M., & Kim, Y. H. (2013) · Cancer Research and Treatment · doi:10.4143/crt.2013.45.2.134 · Cited by 28
Discovery and Mechanism of Natural Products as Modulators of Histone Acetylation
Salvador, L. A., & Luesch, H. (2012) · Current Drug Targets · doi:10.2174/138945012802008973 · Cited by 29
Targeting histone deacetylase in thyroid cancer
Russo, D., Durante, C., Bulotta, S., Puppin, C., Puxeddu, E., Filetti, S., & Damante, G. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.740013 · Cited by 28
“HDACi like VPA that target HDAC6 can also act on a-tubulin [81], and tubulin acetylation has been linked to microtubule dynamics and stability [82].”
BackgroundRegulation of Central Nervous System Development by Class I Histone Deacetylases
D’Mello, S. R. (2019) · Developmental Neuroscience · doi:10.1159/000505535 · Cited by 28
Mangaonkar, S., Nath, S., & Chatterji, B. P. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108726 · Cited by 27
Drake, P. J. M., Griffiths, G. J., Shaw, L., Benson, R., & Corfe, B. M. (2008) · Journal of Proteome Research · doi:10.1021/pr8006396 · Cited by 27
Ramaiah, M. J., Karthikeyan, D., Kumar, S. K., & Yamajala, R. B. R. D. (2019) · Gene · doi:10.1016/j.gene.2019.144126 · Cited by 27
Li, E., Choi, J., Sim, H., Kim, J.-H., Jun, J. H., Kyung, J., Ha, N., Kim, S., Ryu, K. H., Chung, S., et al. (2023) · BMB Reports · doi:10.5483/bmbrep.2022-0157 · Cited by 28
Tala, Sun, X., Chen, J., Zhang, L., Liu, N., Zhou, J., Li, D., & Liu, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090932 · Cited by 27
The role of histone deacetylase 6 (HDAC6) in neurodegeneration
Helleputte, L. V., Benoy, V., & Bosch, L. V. D. (2014) · Research and Reports in Biology · doi:10.2147/rrb.s35470 · Cited by 29
“According to their sequence homology to the yeast Rpd3 protein, HDAC1, 2, 3, and 8 are categorized as class I HDACs.”
Histone Deacetylases and Their Role in Asthma
Royce, S. G., & Karagiannis, T. C. (2012) · Journal of Asthma · doi:10.3109/02770903.2011.648298 · Cited by 27
“Similarly, the class IIb HDAC6 acetylates α-tubulin and microtubules and may have an important role in cellular activation and motility in inflammatory lung diseases (77).”
BackgroundSun, Y., Sun, J., Lungchukiet, P., Quarni, W., Yang, S., Zhang, X. M., & Bai, W. (2015) · Scientific Reports · doi:10.1038/srep11529 · Cited by 27
HDAC6-Pack: Cortactin Acetylation Joins the Brew
Luxton, G. W. G., & Gundersen, G. G. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.07.014 · Cited by 27
Nagata, S., Marunouchi, T., & Tanonaka, K. (2019) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b18-00785 · Cited by 26
Guan, D., Men, Y., Bartlett, A., Hernández, M. A. S., Xu, J., Yi, X., Li, H.-S., Kong, D., Mazitschek, R., & Özcan, U. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.02.007 · Cited by 28
Wang, Y., Wang, K., & Fu, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01893 · Cited by 25
Chawan, V., Yevate, S., Gajbhiye, R., Kulkarni, V., & Parte, P. P. (2020) · Bioscience Reports · doi:10.1042/bsr20202442 · Cited by 25
“The presence of HDAC6 was also seen in the fraction containing soluble tubulin which was not surprising as HDAC6 is known to bind to polymerized as well as soluble tubulin [39].”
The Role of HDAC6 in TDP-43-Induced Neurotoxicity and UPS Impairment
Lee, S., Kwon, Y., Kim, S., Jo, M., Jeon, Y., Cheon, M., Lee, S., Kim, S. R., Kim, K., & Kim, H. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.581942 · Cited by 25
Response to stress in biological disorders: Implications of stress granule assembly and function
Wang, L., Yang, W., Li, B., Yuan, S., & Wang, F. (2021) · Cell Proliferation · doi:10.1111/cpr.13086 · Cited by 28
PROTAC chemical probes for histone deacetylase enzymes
Patel, U., Smalley, J. P., & Hodgkinson, J. T. (2023) · RSC Chemical Biology · doi:10.1039/d3cb00105a · Cited by 25
Histone deacetylase 6’s function in viral infection, innate immunity, and disease: latest advances
Qu, M., Zhang, H., Cheng, P., Wubshet, A. K., Yin, X., Wang, X., & Sun, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1216548 · Cited by 24
“These include a-tubulin (40, 41), heat shock protein 90 (42), cortactin (43), peroxiredoxins (44), b-catenin (45), Ku-70 (46), Tat (47), survivin (48), extracellular signal-regulated kinase-1 (ERK-1) (49, 50), heat shock factor-1 (51), myosin heavy chain 9 (52), heat shock cognate protein 70 (52), dnaJ homolog subfami…”
BackgroundCep70 regulates microtubule stability by interacting with HDAC6
Shi, X., Yao, Y., Wang, Y., Zhang, Y., Huang, Q., Zhou, J., Liu, M., & Li, D. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.06.017 · Cited by 26
Xiong, X., Xu, D., Yang, Z., Huang, H. Y., & Cui, X. (2012) · Journal of Integrative Plant Biology · doi:10.1111/jipb.12003 · Cited by 25
Elongator: An Ancestral Complex Driving Transcription and Migration through Protein Acetylation
Creppe, C., & Buschbeck, M. (2011) · BioMed Research International · doi:10.1155/2011/924898 · Cited by 25
“Defects in both functions of Elongator have been implicated in neurodegenerative disorders.”
Histone acetylation modulation by small molecules: A chemical approach
Rekowski, M. V. W., & Giannis, A. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2010.05.006 · Cited by 25
Histone deacetylase 3 indirectly modulates tubulin acetylation
Bacon, T., Seiler, C., Wolny, M., Hughes, R., Watson, P., Schwabe, J. W. R., Grigg, R., & Peckham, M. (2015) · Biochemical Journal · doi:10.1042/bj20150660 · Cited by 25
ATAT1 regulates forebrain development and stress-induced tubulin hyperacetylation
Li, L., Jayabal, S., Ghorbani, M., Legault, L., McGraw, S., Watt, A. J., & Yang, X. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03088-3 · Cited by 25
George, S., Kadam, S. D., Irving, N. D., Markowitz, G. J., Raja, S., Kwan, A., Tu, Y., Chen, H., Rohde, C. A., Smith, D. R., et al. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00123 · Cited by 25
“Frontiers in Cellular Neuroscience www.frontiersin.org August 2013 | Volume 7 | Article 123 | 1 “fncel-07-00123” — 2013/8/16 — 16:00 — page 2 — #2 HDAC inhibitors can, however, also decrease activation of some genes by increasing gene repressor transcription.”
BackgroundInfluentialKomorowsky, C. V., Ocker, M., & Goppelt‐Struebe, M. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00674.x · Cited by 24
“Valproic acid was less effective, whereas sodium butyrate, which does not inhibit HDAC-6, a tubulin deacetylase [35], clearly induced CTGF expression.”
BackgroundAssessment of the Effect of Trichostatin A on HeLa Cells through FT-IR Spectroscopy
Zhang, F., Huang, Q., Yan, J., Zhang, X., & Li, J. (2015) · Analytical Chemistry · doi:10.1021/ac504691q · Cited by 24
Microtubule dynamics regulates Akt signaling via dynactin p150
Jo, H., Loison, F., & Luo, H. R. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.04.007 · Cited by 24
Sixto‐López, Y., Bello, M., & Correa‐Basurto, J. (2018) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2018.1557560 · Cited by 23
Wang, D., Wang, B., Liu, Y., Dong, X., Su, Y., & Li, S. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02882-6 · Cited by 24
Bielak-Żmijewska, A., Sikora-Polaczek, M., Nieznański, K., Mosieniak, G., Kolano, A., Maleszewski, M., Styrna, J., & Sikora, E. (2010) · Cell Proliferation · doi:10.1111/j.1365-2184.2010.00684.x · Cited by 24
Yerbes, R., & López‐Rivas, A. (2010) · Investigational New Drugs · doi:10.1007/s10637-010-9597-x · Cited by 23
“In addition, a number of non-histone proteins may also be modified by acetylation and therefore, HDAC inhibition may affect different cellular processes [33, 34].”
BackgroundCritical review of non‐histone human substrates of metal‐dependent lysine deacetylases
Toro, T. B., & Watt, T. J. (2020) · The FASEB Journal · doi:10.1096/fj.202001301rr · Cited by 24
HDAC6 Inhibition Extinguishes Autophagy in Cancer: Recent Insights
Passaro, E., Papulino, C., Chianese, U., Toraldo, A., Congi, R., Gaudio, N. D., Nicoletti, M. M., Benedetti, R., & Altucci, L. (2021) · Cancers · doi:10.3390/cancers13246280 · Cited by 25
“It is known to deacetylate α-tubulin and increase cell motility through its deacetylase activity on non-histone substrates (Figure 2a) [79].”
BackgroundGivinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics
Taiarol, L., Bigogno, C., Sesana, S., Kravicz, M., Viale, F., Pozzi, E., Monza, L., Carozzi, V., Meregalli, C., Valtorta, S., et al. (2022) · Cancers · doi:10.3390/cancers14122978 · Cited by 23
“Of note, cytosolic HDAC6 is a microtubule-associated protein whose task is to deacetylate non-histonic proteins such as α-tubulin [56], thus explaining the increase in its acetylation induced by the treatment with LIP/m-GIV.”
BackgroundA Review on Molecular Docking on HDAC Isoforms: Novel Tool for Designing Selective Inhibitors
Drakontaeidi, A., & Pontiki, E. A. (2023) · Pharmaceuticals · doi:10.3390/ph16121639 · Cited by 24
“The HDAC6 enzyme is classified under class IIb of HDACs, and it possesses a distinct characteristic of deacetylating other non-histone substrates of significant importance, including tubulin and p53 [124,125].”
BackgroundRole of Histone Deacetylase 6 and Histone Deacetylase 6 Inhibition in Colorectal Cancer
Vuletić, A. M., Martinović, K. M., & Spasić, J. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics16010054 · Cited by 24
“…substrates for deacetylation by HDAC6 include α -tubulin, cortactin, heat shock protein (Hsp) 90, heat shock transcription factor-1 (HSF-1), Ku70, p53, peroxiredoxins, signal transducer and activator of transcription (STAT) 3, forkhead box protein O1 (FOXO1), and β -Catenin [17,18,23–25] (Table 1).”
BackgroundLi, J., Song, J., Cassidy, M. G., Rychahou, P. G., Starr, M. E., Liu, J., Li, X., Epperly, G., Weiss, H. L., Townsend, C. M., et al. (2012) · Molecular Endocrinology · doi:10.1210/me.2012-1024 · Cited by 25
Zhang, Z., Meng, T., He, J., Li, M., Tong, L., Xiong, B., Lin, L., Shen, J., Miao, Z., & Ding, J. H. (2009) · Investigational New Drugs · doi:10.1007/s10637-009-9303-z · Cited by 23
Demyanenko, S. V., Dzreyan, V., & Uzdensky, A. B. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.06.010 · Cited by 23
Role of HDAC6 and Its Selective Inhibitors in Gastrointestinal Cancer
Zhou, B., Liu, D., & Tan, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.719390 · Cited by 23
“Moreover, it regulates cell migration, invasion, adhesion, and microtubule and skeletal dynamics through deacetylation of tubulin and cortactin (Miyake et al., 2016; Zhang et al., 2003) (Figure 2C).”
BackgroundRegulation and Processing of Maize Histone Deacetylase Hda1 by Limited Proteolysis
Pipal, A., Goralik-Schramel, M., Lusser, A., Lanzanova, C., Sarg, B., Loidl, A., Lindner, H. H., Rossi, V., & Loidl, P. (2003) · The Plant Cell · doi:10.1105/tpc.013995 · Cited by 23
“…also is possible that ZmHda1 is enzymatically active toward nonhistone proteins, as was shown recently for HDAC6 and tubulin (Hubbert et al., 2002; Zhang et al., 2003), and then is converted to p48 with altered substrate specificity (core histones) by phosphorylation/dephosphorylation-triggered…”
BackgroundMechanism for neurotropic action of vorinostat, a pan histone deacetylase inhibitor
Shukla, S., Shariat‐Madar, Z., Walker, L., & Tekwani, B. L. (2016) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2016.09.003 · Cited by 22
Manzotti, G., Torricelli, F., Donati, B., Sancisi, V., Gugnoni, M., & Ciarrocchi, A. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1350-5 · Cited by 22
Cosenza, M., Civallero, M., Marcheselli, L., Sacchi, S., & Pozzi, S. (2020) · APOPTOSIS · doi:10.1007/s10495-020-01607-3 · Cited by 22
Histone Deacetylases and Their Isoform-Specific Inhibitors in Ischemic Stroke
Demyanenko, S. V., Dzreyan, V., & Sharifulina, S. (2021) · Biomedicines · doi:10.3390/biomedicines9101445 · Cited by 22
“Its deacetylation induced destabilization of microtubules in the course of cytoskeleton reorganization and axonal growth during post-stroke regeneration [72].”
BackgroundThe Altered Hepatic Tubulin Code in Alcoholic Liver Disease
Groebner, J. L., & Tuma, P. L. (2015) · Biomolecules · doi:10.3390/biom5032140 · Cited by 22
Torres, O. V., Ladenheim, B., Jayanthi, S., McCoy, M. T., Krasnova, I. N., Vautier, F., & Cadet, J. L. (2015) · Neurotoxicity Research · doi:10.1007/s12640-015-9591-3 · Cited by 22
“2002), while inactivation of HDAC6 leads to tubulin hyperacetylation (Zhang et al. 2003).”
Uba, A. İ., & Yelekçi, K. (2018) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2018.05.004 · Cited by 22
Amargant, F., Barragán, M., Vassena, R., & Vernos, I. (2018) · Biology of Reproduction · doi:10.1093/biolre/ioy203 · Cited by 23
Zinc Dependent Histone Deacetylase Inhibitors in Cancer Therapeutics: Recent Update
Sultana, F., Manasa, K. L., Shaik, S. P., Bonam, S. R., & Kamal, Ä. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180530094120 · Cited by 21
Uba, A. İ., & Yelekçi, K. (2018) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2018.10.016 · Cited by 22
Development of Thiazolidinedione-Based HDAC6 Inhibitors to Overcome Methamphetamine Addiction
Sharma, C., Oh, Y. J., Park, B., Lee, S., Jeong, C., Lee, S. K., Seo, J. H., & Seo, Y. H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246213 · Cited by 21
“Histone H3 and α -tubulin are well-known substrates of HDAC1 and HDAC6 [23,24].”
Kim, D. H., Lee, J., Kim, K. N., Kim, H. J., Jeung, H., Chung, H. C., & Kwon, H. J. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.02.126 · Cited by 21
Mahalingam, D., Mita, A. C., Mita, M. M., Nawrocki, S. T., & Giles, F. J. (2009) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2009.03.001 · Cited by 21
Posttranslational Modifications of Tubulin
Chao, S. K., Yang, C. H., & Horwitz, S. B. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-788-0_13 · Cited by 21
In vitro and in vivo activity of a new small-molecule inhibitor of HDAC6 in mantle cell lymphoma
Pérez-Salvia, M., Aldaba, E., Vara, Y., Fabre, M., Cristina, F., Masdeu, C., Zubia, A., Sebastián, E. S., Otaegui, D., Llinàs‐Arias, P., et al. (2018) · Haematologica · doi:10.3324/haematol.2018.189241 · Cited by 20
“Trichostatin A was used as a general inhibitor for HDAC classes I, IIa, IIB (including HDAC6) and IV, whereas sodium butyrate was used as an HDAC inhibitor that does not affect HDAC6 (Figure 1C).(14) The three available HDAC6 inhibitors (tubastatin A, tubacin, and ACY1215) were also used as specific positive controls…”
Wang, Q., & Liu, X. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01453-y · Cited by 21
Gomes, I. D., Ariyaratne, U. V., & Pflum, M. K. H. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.1c00303 · Cited by 21
Srinivasaraghavan, V., Strobl, J. S., & Agah, M. (2012) · Lab on a Chip · doi:10.1039/c2lc40778g · Cited by 20
KDAC8 substrate specificity quantified by a biologically relevant, label‐free deacetylation assay
Toro, T. B., & Watt, T. J. (2015) · Protein Science · doi:10.1002/pro.2813 · Cited by 20
“c Previously reported as a substrate but not characterized with absolute rate.(59) d Data from Table II repeated for comparison.”
BackgroundYoo, J., Kim, S., Son, D., Seo, H., Baek, S. Y., Maeng, C.-Y., Lee, C., Kim, I. S., Jung, Y. H., Lee, S., et al. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.03.046 · Cited by 20
Targeting post-translational histone modifications for the treatment of non-medullary thyroid cancer
Celano, M., Mio, C., Sponziello, M., Verrienti, A., Bulotta, S., Durante, C., Damante, G., & Russo, D. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.05.036 · Cited by 21
“The synergistic effect with 244 paclitaxel is due to the fact that VPA and paclitaxel both affect microtubule dynamics and stability 245 (Matsuyama 2002; Zhang et al., 2003; Catalano et al., 2012b, Catalano et al., 2007).”
BackgroundWong, V. S. C., Picci, C., Swift, M. L., Levinson, M., Willis, D. E., & Langley, B. C. (2018) · eNeuro · doi:10.1523/eneuro.0240-17.2018 · Cited by 20
“Previous studies have shown that -tubulin K40 deacetylation is a primary and non-nuclear function of the class II zinc-dependent histone deacetylase (HDAC) family member, HDAC6 (Zhang et al., 2003; Zhang et al., 2008).”
BackgroundSalian‐Mehta, S., Xu, M., McKinsey, T. A., Tobet, S. A., & Wierman, M. E. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.640482 · Cited by 19
Khotskaya, Y. B., Beck, B. H., Hurst, D. R., Han, Z., Xia, W., Hung, M., & Welch, D. R. (2013) · Molecular Carcinogenesis · doi:10.1002/mc.22068 · Cited by 20
“As recent publications show, tubulin can be deacetylated and thus destabilized in the cytoplasm through actions of a major cytoplasmic histone deacetylase, HDAC6 [68,69] and these posttranslational modifications define its cytoskeletal”
BackgroundInfluentialPinna, G. A., Murineddu, G., Murruzzu, C., Zuco, V., Zunino, F., Cappelletti, G., Artali, R., Cignarella, G., Solano, L., & Villa, S. (2009) · ChemMedChem · doi:10.1002/cmdc.200800428 · Cited by 20
Moreth, K., Riester, D., Hildmann, C., Hempel, R., Wegener, D., Schober, A., & Schwienhorst, A. (2007) · Biochemical Journal · doi:10.1042/bj20061239 · Cited by 20
Tavares, M. T., de Almeida, L. C., Kronenberger, T., Ferreira, G. M., de Divitiis, T. F., Toledo, M. F. Z. J., Hassimotto, N. M. A., Machado‐Neto, J. A., Costa-Lotufo, L. V., & Parise‐Filho, R. (2021) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2021.116085 · Cited by 19
N-α-acetyltransferase 10 (NAA10) in development: the role of NAA10
Lee, M.-N., Kweon, H. Y., & Oh, G. T. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0105-2 · Cited by 19
Ryhänen, T., Viiri, J., Hyttinen, J. M. T., Uusitalo, H. M. T., Salminen, A., & Kaarniranta, K. (2010) · BioMed Research International · doi:10.1155/2011/798052 · Cited by 20
“Hindawi Publishing Corporation Journal of Biomedicine and Biotechnology Volume 2011, Article ID 798052, 8 pages doi:10.1155/2011/798052”
InfluentialSubstrate specificity and function of acetylpolyamine amidohydrolases from Pseudomonas aeruginosa
Krämer, A., Herzer, J., Overhage, J., & Meyer‐Almes, F. (2016) · BMC Biochemistry · doi:10.1186/s12858-016-0063-z · Cited by 19
“53 % to the second domain of human HDAC6, a proven deacetylase of several cytosolic proteins [27–29].”
BackgroundN-Hydroxy-7-(2-naphthylthio) Heptanomide Inhibits Retinal and Choroidal Angiogenesis
Kim, J. H., Kim, J. H., Oh, M., Yu, Y. S., Kim, K.-W., & Kwon, H. J. (2009) · Molecular Pharmaceutics · doi:10.1021/mp800178b · Cited by 19
Jeong, H. S., Kim, H. J., Kim, D., Chung, K. W., Choi, B., & Lee, J. E. (2022) · Molecules and Cells · doi:10.14348/molcells.2022.5005 · Cited by 18
“In particular, (de)acetylation of Lys40 of α -tubulin in the lumen of microtubules is modulated by α -tubulin acetyl-transferase ( α TAT) and HDAC6 (Asthana et al., 2013; Kalebic et al., 2013; Zhang et al., 2003).”
Gey, C., Kyrylenko, S., Hennig, L., Nguyen, L. D., Büttner, A., Pham, H. D., & Giannis, A. (2007) · Angewandte Chemie · doi:10.1002/ange.200605207 · Cited by 18
Inhibition of HDAC6 activity through interaction with RanBPM and its associated CTLH complex
Salemi, L. M., Maitland, M. E. R., Yefet, E. R., & Schild‐Poulter, C. (2017) · BMC Cancer · doi:10.1186/s12885-017-3430-2 · Cited by 18
“Since HDAC6 associates with α-tubulin [17], we wanted to determine whether RanBPM was necessary for HDAC6 association with α-tubulin and vice versa.”
BackgroundInfluentialLoi, M., Gennaccaro, L., Fuchs, C., Trazzi, S., Medici, G., Galvani, G., Mottolese, N., Tassinari, M., Rimondini, R., Milelli, A., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115950 · Cited by 18
“Since tubulin is a substrate of HDAC6 [34], to confirm the inhibitory activity of C11 on HDAC6, we investigated acetylated tubulin levels in untreated and treated SHCDKL5-KO cells.”
BackgroundLi, Z., Xiao, W., Yang, Z., Guo, J., Zhou, J., Xiao, S., Fang, P., & Fang, L. (2024) · Journal of Virology · doi:10.1128/jvi.01814-23 · Cited by 17
“It is well known that α-tubulin is a substrate for HDAC6 deacetylation, and alterations in the acetylation level of α-tubulin have been used extensively to assess changes in HDAC6 deacetylase activity (44, 45).”
BackgroundMorgado, J., Diniz, L. P., Araújo, A. P. B., Antônio, L. M. D. S., Mota-Araujo, H. P., Pinheiro, P. D. S. M., Sagrillo, F. S., Vargas, G., Ferreira, S. T., Figueiredo, C. P., et al. (2024) · British Journal of Pharmacology · doi:10.1111/bph.16439 · Cited by 18
“…events controlled by deacetylation of histone and nonhistone proteins, such as microtubule dynamics and axonal transport, apoptotic cell death, misfolded protein clearance, cellular stress prevention and chaperone expression (Boyault et al., 2007; Carlomagno et al., 2017; Y. Zhang et al., 2003).”
Guo, S.-D., Yan, S., Li, W., Zhou, H., Yang, J., Yao, Y., Shen, M.-J., Zhang, L., Zhang, H., & Sun, L.-C. (2020) · Aging · doi:10.18632/aging.102964 · Cited by 17
LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression
Xu, X., Ding, P., Shi, L., Wu, G., & Ma, X. (2022) · BMC Cancer · doi:10.1186/s12885-022-09680-4 · Cited by 16
“In addition, it has been reported that HDAC6 can regulate the acetylation of α-tubulin and, thus, participate in tumor development [33].”
BackgroundZinc-Dependent Histone Deacetylases in Lung Endothelial Pathobiology
Patil, R. S., Maloney, M. E., Lucas, R., Fulton, D. J., Patel, V. S., Bagi, Z. A., Kovács‐Kása, A., Kovács, L., Su, Y., & Verin, A. D. (2024) · Biomolecules · doi:10.3390/biom14020140 · Cited by 15
“HDAC6 is directly deacetylated α -tubulin at Lys 40 [167], thus promoting MT disassembly in human pulmonary ECs [168].”
BackgroundChromatin modification and epigenetic control in functional nerve regeneration
Berry, K., & Lu, Q. R. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.07.009 · Cited by 17
HDAC inhibitor ameliorates behavioral deficits in Mecp2308/y mouse model of Rett syndrome
Lebrun, N., Delépine, C., Selloum, M., Méziane, H., Nectoux, J., Hérault, Y., & Bienvenu, T. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147670 · Cited by 14
Bag, A. K., Schultz, A., Bhimani, S., Stringfield, O., Dominguez, W., Mo, Q., Cen, L., & Adeegbe, D. O. (2022) · OncoImmunology · doi:10.1080/2162402x.2022.2042065 · Cited by 17
Du, G., & Jiao, R. (2011) · Communicative & Integrative Biology · doi:10.4161/cib.4.2.14272 · Cited by 16
Mao, P., He, W., Mai, X., Feng, L.-H., Li, N., Liao, Y.-J., Zhu, C., Li, J., Chen, T., Liu, S.-H., et al. (2021) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2021.116599 · Cited by 9
Jha, S., Kim, J. H., Kim, M., Nguyen, A.-H., Ali, K. H., Gupta, S., Park, S. Y., Ha, E., & Seo, Y. H. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.116057 · Cited by 15
Hypothesis: NDL proteins function in stress responses by regulating microtubule organization
Khatri, N., & Mudgil, Y. (2015) · Frontiers in Plant Science · doi:10.3389/fpls.2015.00947 · Cited by 15
“Microtubule dynamics is affected by an array of reversible post-translational modifications including acetylation, phosphorylation, and palmitoylation (Piperno et al., 1987; Westermann and Weber, 2003; Zhang et al., 2003).”
BackgroundStructure–Activity Relationship of Propargylamine‐Based HDAC Inhibitors
Wünsch, M., Senger, J., Schultheisz, P., Schwarzbich, S., Schmidtkunz, K., Michalek, C., Klaß, M., Goskowitz, S., Borchert, P., Praetorius, L., et al. (2017) · ChemMedChem · doi:10.1002/cmdc.201700550 · Cited by 14
Hu, Z., Rong, Y., Li, S., Qu, S., & Huang, S. (2020) · Cancer Management and Research · doi:10.2147/cmar.s284199 · Cited by 15
Histone acetylation modulators in breast cancer
Yuan, X., & Rosen, J. M. (2025) · Breast Cancer Research · doi:10.1186/s13058-025-02006-9 · Cited by 14
Cross-seeding by prion protein inactivates TDP-43
Polido, S. A., Stuani, C., Voigt, A., Banik, P., Kamps, J., Bader, V., Grover, P. L., Krause, L. J., Zerr, I., Matschke, J., et al. (2023) · Brain · doi:10.1093/brain/awad289 · Cited by 15
Metadata
- Authors
- Zhang, Y., Li, N., Caron, C., Matthias, G., Hess, D., Khochbin, S., & Matthias, P.
- Affiliations
- Friedrich Miescher Institute (CH)
- Inserm (FR)
- Corresponding author
- Matthias, Patrick
- Venue
- The EMBO Journal
- Published
- 2003-03-03
- Volume
- 22
- Issue
- 5
- Pages
- 1168-1179
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC150348
- OpenAlex
- W1979832500
- Cited by
- 740
- References
- 38
- Citations by year
- 2026: 26 · 2025: 20 · 2024: 27 · 2023: 37 · 2022: 24 · 2021: 29 · 2020: 35 · 2019: 29 · 2018: 32 · 2017: 22 · 2016: 39 · 2015: 35 · 2014: 26 · 2013: 45 · 2012: 41
- FWCI
- 9.19
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The EMBO Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Harvard University
- University of California, San Francisco
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- histone deacetylase, tubulin deacetylation, alpha-tubulin, beta-tubulin, microtubules, tubulin acetylation, microtubule dynamics, histone deacetylase inhibitors, non-histone protein acetylation, cytoskeleton
- MeSH terms
- Histone Deacetylase 6, Acetylation, Animals, Cattle, Chromatography, High Pressure Liquid, Embryo, Mammalian, Histone Deacetylases, Humans, Kidney, Microtubules, Peptides, Protein Binding, Stem Cells, Tubulin, 3T3 Cells, Paclitaxel, Protein Structure, Tertiary, Two-Hybrid System Techniques, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
